AlphAIAlphAI — Financial news for AI agents
tradingview.comOCT 282 min read$GEHC

GE HealthCare 3Q 2026: Revenue $5.51B, Net income $615M, EPS $1.36— 10-Q Summary

GE HealthCare reported Q3 2026 revenue of $5.51B, up 7.2% YoY, with net income at $615M and EPS at $1.36. Growth was driven by Pharmaceutical Diagnostics and Advanced Imaging Solutions, while U.S. and Canada revenue rose 13.3%.

Original reporting
tradingview.com
Published Oct 28, 2026, 10:31 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 28, 2026, 10:40 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
GE HealthCare 3Q 2026: Revenue $5.51B, Net income $615M, EPS $1.36— 10-Q Summary — source image
Source · tradingview.com
Decision brief

The 30-second read

$GEHCBullishMed
01

Why it matters

The earnings beat suggests near‑term upside for the stock, while organic growth in PDx and AIS underscores longer‑term momentum.

02

Market read

First disclosure of Q3 2026 results for a large mid‑cap healthcare company; relevant for traders seeking earnings‑driven moves.

03

What to watch

Geopolitical headwinds in China and tariff costs could pressure margins despite the beat.

Relevance 8/10Novelty 8/10Timing: post‑market today

Background

The article summarizes the Q3 2026 10‑Q filing for GE HealthCare Technologies, highlighting key financial metrics and segment performance.

Company-level read

Ticker impact

$GEHCBullishHigh confidence
Context

GE HealthCare Technologies reported Q3 2026 revenue of $5.51B, net income $615M and EPS $1.36, all up YoY.

Expected impact

likely upward pressure as the market prices in the earnings beat

Evidence & confidence

The company posted double‑digit profit growth and revenue beat, which typically drives short‑term buying.

Market effects

Sector

Strong results may lift the broader medical‑technology sector.

Regional

U.S. and Canada revenue growth could boost North American healthcare indices.

Global

Modest impact globally; European and Asian markets may see limited reaction.

Counterpoint

What could challenge this read

If guidance falls short of expectations, the rally could be short‑lived.

Key entities

  • company
    GE HealthCare Technologies

    U.S.-listed medical‑technology firm (ticker GEHC).

Read at source← All news

StoryGE HealthCare reports strong third-quarter growth and raises 2026 outlook

Also covered by

6 outlets

Related articles

OCT 28
$GEHCHighAI 9/10

GE HealthCare Surges on Q3 Beat and Raised Outlook

GE HealthCare (GEHC) shares rose 5.4% in pre-market trading after Q3 2026 earnings beat estimates, with adjusted EPS of $1.34 vs. $1.20 consensus and revenue of $5.5B vs. $5.35B. The company raised full-year EPS guidance to $4.95–$5.05. CEO Peter Arduini cited strong growth and margin expansion. Free cash flow increased to $793M, up $310M year-over-year.

tradingpedia.com6 min
OCT 28
$GEHCHighAI 9/10

Why is GE HealthCare stock surging today?

GE HealthCare (GEHC) stock rose 5.4% in pre-market trading after its Q3 2026 results exceeded expectations, with adjusted EPS of $1.34 vs. $1.20 expected, and revenue of $5.5B vs. $5.35B. The company raised its full-year guidance, citing strong growth and margin expansion. Short interest at 18.5M shares amplified the upside move. CEO Peter Arduini highlighted growth across all segments and noted no structural barriers in China.

investing.com2 min
OCT 28
$GEHCMedAI 8/10

GE HealthCare Q3 Revenue Rises 7.2% to $5.5 Billion

GE HealthCare reported Q3 2026 revenue of $5.5B, up 7.2% YoY. Organic revenue and orders grew 6.2% and 4%, respectively. Net income rose to $615M from $446M, with margins improving. The company raised its full-year 2026 guidance, citing strong performance and momentum.

grafa.com2 min
OCT 28
$GEHCHighAI 9/10

GE HealthCare’s (NASDAQ:GEHC) Q3 2026 sales beat estimates

GE HealthCare reported Q3 2026 revenue of $5.51B, exceeding estimates by 3% and growing 7.2% YoY. Adjusted EPS was $1.34, beating estimates by 11.3%. The company raised its full-year adjusted EPS guidance to $5 at the midpoint. Operating and free cash flow margins improved to 14.6% and 14.4%, respectively, up from the prior year.

finance.yahoo.com1 min